Tag: AbbVie-Allergan Deal
EU: AbbVie-Allergan US$63B deal cleared
The European Commission approved AbbVie's merger with Allergan on the condition the companies sell off Allergan's late-stage IL-23 inhibitor brazikumab. That stipulation is far...
US: FTC wants more information on AbbVie-Allergan deal
The Federal Trade Commission (FTC) has made a request for additional information regarding AbbVie’s proposed US$63 billion purchase of Allergan, reported Reuters.
The deal, announced...
